HECTD1 and androgen insensitivity syndrome: CircRNA HECTD1 expression was increased in AIS recurrence patients compared to non‐recurrence patients, and further, ROC curve analysis disclosed that circRNA HECTD1 expression predicted higher risk of AIS recurrence (AUC: 0.694, 95% CI: 0.586‐0.801).